Title:
ＥＲＴ２変異体及びその使用方法
Document Type and Number:
Japanese Patent JP2024513231
Kind Code:
A
Abstract:
本明細書では、エストロゲン受容体アルファリガンド結合ドメイン（ＥＲ－ＬＢＤ）の変異体、及びそのような変異ＥＲ－ＬＢＤを含むキメラタンパク質が提供される。転写を調節し、そのようなキメラタンパク質の局在化を調節する方法もまた提供される。【選択図】図１Ａ
Inventors:
Han Michel Elizabeth
cotman rebecca taylor
Gordry Russell Morrison
lee gary
Lou Timothy Quanta
Kannan Srinivasaraghavan
Varma Chandra Shekhar
cotman rebecca taylor
Gordry Russell Morrison
lee gary
Lou Timothy Quanta
Kannan Srinivasaraghavan
Varma Chandra Shekhar
Application Number:
JP2023561275A
Publication Date:
March 22, 2024
Filing Date:
April 06, 2022
Export Citation:
Assignee:
Senti Biosciences Incorporated
International Classes:
C12N15/12; C07K14/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/62; C12N15/63
Attorney, Agent or Firm:
Hatsushi Shimizu
Hideki Kodera
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Maki Shioda
Kazuya Kawamoto
Naoko Sakai
Edamatsu Yoshie
Hideki Kodera
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Maki Shioda
Kazuya Kawamoto
Naoko Sakai
Edamatsu Yoshie
Previous Patent: Intravenous filter with priming function
Next Patent: Drug-regulatable transcriptional repressors
Next Patent: Drug-regulatable transcriptional repressors